期刊文献+

神经节苷脂联合马来酸桂哌齐特治疗血管性痴呆25例疗效观察 被引量:3

暂未订购
导出
摘要 血管性痴呆是老年性痴呆中最常见的类型之一,患病率仅次于Alzheimer病。在65岁以上人群中痴呆的发病率为5%,而血管性痴呆占20%左右。本文运用神经节苷脂联合马来酸桂哌齐特对血管性痴呆进行治疗,现报告如下。
作者 张艺凡
出处 《贵州医药》 CAS 2012年第7期615-616,共2页 Guizhou Medical Journal
  • 相关文献

参考文献4

二级参考文献12

  • 1张亚哲,赵耕源,张书刚,韩自力,关念红.冠心病患者心理状态的临床研究[J].中国神经精神疾病杂志,1997,23(3):159-162. 被引量:40
  • 2陈建平,顾卫平,卢尔滨,杨丽春.冠心病患者情绪障碍调查[J].中国心理卫生杂志,1997,11(3):142-144. 被引量:143
  • 3Inoue K,Takano H,Shimada A,et al.Urinary Trypsine inhibitor protects against systemic inflammation induced by lipopolysaccharide[J].Mol Pharmacol,2005,67:673-680.
  • 4Minamiya Y,Abo S,Kitamura M,et al.Endotoxia-induced hydrogen peroide production in intact pulmonary circulation of rat[J].Am J RespirCrit Care Med,1995,152:348-354.
  • 5Schutte H,Witzenrath M,Mayer K,et al.Short-term "preconditioning" with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury[J].J Transplantation,2001,72(8):1 363-137.
  • 6Terence HR,Warren M,Raymond PW,et al.Evidence for free radical mediated lipid peroxidation at reperfusion of human orthotopic liver transplantats[J].Surgery,1994,115:94-101.
  • 7Andrew P,Halestrap,Samantha J,et al.Mitochondrial permeability transition pore opening during myocardial reperfusiona target for cardioprotection[J].Cardiovascular Research,2004,61:372-385.
  • 8张京立,张红红,陶国枢,刘晓玲,吴青,季晓莉,林娜,张彬.北京海淀区1390名老年人老年期痴呆流行病学调查[J].中华流行病学杂志,1998,19(1):18-20. 被引量:34
  • 9廖维靖.脑缺血损伤的病理生理机制-损伤级联反应[J].国外医学(脑血管疾病分册),1998,6(4):197-202. 被引量:128
  • 10周农,尹世杰,尹长林,付佳,胡孝全,邱学宏.多发性梗塞性痴呆发病的相关因素分析[J].临床神经病学杂志,1999,12(4):227-228. 被引量:16

共引文献25

同被引文献34

  • 1曹梦苒,华海清,秦叔逵.神经节苷脂预防奥沙利铂周围神经毒性的研究[J].肿瘤防治研究,2014,41(4):387-390. 被引量:21
  • 2甘廷庆,杨丽桦,蓝东,刘汉锋.谷胱甘肽联合左卡尼汀预防奥沙利铂化疗的周围神经毒性疗效观察[J].医学临床研究,2013,30(6):1065-1067. 被引量:3
  • 3王敏.单唾液酸四己糖神经节苷脂防治奥沙利铂周围神经毒性的疗效[J].中国老年学杂志,2015,35(2):501-502. 被引量:9
  • 4陈濒珠.实用内科学[M].12版.北京:人民卫生出版社,2005:230.
  • 5Kimn J,Park HR,Roh ILl,et al.Chemotherapy-related polyncu-ropathymay deteriorate quality of life in patients with B-cell lymphoma[J].OaalLife Hes,2019,19(8):1 097-1 103.
  • 6Park SB,Goldstein D,Lin CS,et al.Acute abnormalities sensory nervefunction associated with oxaliplatin induce neurotoxicity[J].Clin Oncol,2009,27(8):1243-1249.
  • 7Manji H.Toxic neuropathy[J].Curr Opin Neurol,2011,24(5):484-490.
  • 8Khattak MA.Calcium and magnesium prophyla:ds for oxaliplatirr relatedneurotoxicity:is it a trade-off between drug efficacy and toxicity[J].On-cologist,2011,16(12):1780-1783.
  • 9P Durand,G Deplanque.Efficacy of venlafaxine for the prevention and re-lief of oxaliplatin induced acute neurotoxicity:results of EFFOX,a random-ized? double-blind,placebo-controlled phase Ⅲ trial[J].Ann Oncol,2012,11:9.
  • 10Durand JP.Efficacy of venlafaxine for the prevention and relief of oxali-platin-induced acute neurotoxicity:results of EFFOX,a randomized,double-blind,placebo-controlled phase HI trial[J].Ann 0neol,2012,23(1):200.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部